Funder: NIH National Institute on Drug Abuse (NIDA)

The purpose of this notice is to communicate NIDA’s interest in supporting research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection. This Notice is a reissuance of NOT-DA-20-084.

Research Objectives: NIDA is interested in receiving research applications focusing on individuals who smoke or vape either marijuana and/or tobacco to determine: 1) the risk of contracting a COVID-19 infection, 2) the effects on asymptomatic COVID-19 infected persons, and 3) the course of the COVID-19 infection.

This NOSI encourages research to understand:

• The risks that smoking or vaping tobacco or marijuana may have on acquiring the COVID-19 infection.
• The medical consequences, co-morbidity, and complications of COVID-19 infection in individuals who smoke or vape tobacco or marijuana.
• The medical consequences of COVID-19 in individuals who smoke and vape with comorbid conditions such as: SUD, HIV and other immunosuppressive diseases, mental health disorders, diabetes mellitus, obesity, cardiovascular, pulmonary, renal, and hepatic pathologies, as well as cancer.

Topics: Co-Morbidities, Asthma, Cancer, Cardiovascular Disease, Cirrhosis, COPD, COVID-19, Diabetes, Gastroesophageal Reflux Disease (GERD), Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Substance Abuse, Epidemiology, Clinical History, Clinical Outcome, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Target Population, Elderly, Teens